Wow, didn't see that coming. Market cap hovered at what, around $30 million total for a while.
Gee, guess anything can happen on low volume trades every hour. I wish I had a bid in. I am upset that the company has no news to report so close to October. But I still believe the science is just as logical as anywhere else and no major clinical trial results out yet for so many ongoing tests. All I can do is wait it out.
about 34 cents a share is net value of ENMD (cash minus debt, remember they mortgaged the royalty revenue back in 2006). This is saying the patents are worthless (someone has a better mouse trap and we are too dumb to know about it, or a bigger, badder stock sale is looming.) I'm betting on 20 cents a share sometime soon. If you think I'm nuts go ahead and put your GTC order in now, big guy. Watch it get filled.